Fort LP’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,480
Closed -$234K 134
2023
Q2
$234K Buy
+2,480
New +$216K 0.62% 107
2022
Q3
Sell
-4,091
Closed -$389K 211
2022
Q2
$389K Sell
4,091
-2,055
-33% -$213K 0.26% 179
2022
Q1
$724K Buy
6,146
+2,632
+75% +$295K 0.27% 180
2021
Q4
$455K Buy
+3,514
New +$410K 0.15% 232
2021
Q2
Sell
-2,875
Closed -$240K 280
2021
Q1
$240K Sell
2,875
-1,071
-27% -$90.5K 0.07% 238
2020
Q4
$360K Sell
3,946
-1,060
-21% -$87.9K 0.11% 230
2020
Q3
$400K Buy
5,006
+2,101
+72% +$164K 0.17% 240
2020
Q2
$201K Buy
2,905
+1,315
+83% +$93.5K 0.11% 266
2020
Q1
$100K Buy
1,590
+90
+6% +$6.49K 0.02% 318
2019
Q4
$117K Buy
+1,500
New +$117K 0.02% 333
2019
Q3
Sell
-2,088
Closed -$129K 445
2019
Q2
$129K Sell
2,088
-3,714
-64% -$225K 0.02% 322
2019
Q1
$370K Buy
5,802
+1,293
+29% +$73.8K 0.07% 261
2018
Q4
$230K Buy
4,509
+39
+0.9% +$1.97K 0.05% 264
2018
Q3
$259K Buy
4,470
+3,036
+212% +$148K 0.06% 239
2018
Q2
$70K Buy
+1,434
New +$66.9K 0.02% 221

Other funds holding EW

Fort LP's EW Position: Q3 2023 in Review

Fort LP sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 2,480 shares — an estimated $234K sold.

Fort LP first reported a position in EW in Q2 2018 and held it in 15 quarters. The position peaked at $724K in Q1 2022. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Fort LP reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Fort LP sold 2,480 Edwards Lifesciences shares in Q3 2023, an estimated $234K.
  • Fort LP first reported a position in Edwards Lifesciences in Q2 2018 and held it in 15 quarters.
  • Fort LP's Edwards Lifesciences position peaked at $724K in Q1 2022.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Fort LP's 13F filing for Q3 2023, filed 13 Nov 2023.